SWOG S1826

Primary Category:

Radiation Oncology, Treatment Protocols

Disease Category:

Hodgkin Lymphoma, Lymphoma

Status:

New, Open

A Phase III, Randomized Study of Nivolumab (Opdivo) Plus AVD or Brentuximab Vedotin (Adcetris) Plus AVD in Patients (Age >/= 12 Years) with Newly Diagnosed Advanced Stage Classical Hodgkin Lymphoma

NCT#03907488

Eligible for screening study DCP 001